INSUBCONTINENT EXCLUSIVE:
health and medical products.During a meeting on Saturday, the two officials discussed the creation of a market for health and medical
obstacles to the development of cooperation should be removed, and speed up the process of work in customs and issuing licenses, he further
highlighted.Cooperation between the two countries in the production of medicine and medical equipment can meet the needs of regional
markets.He went on to note that both countries must try to stand on their own feet
products creates employment as well as production and business prosperity and activates the common market between the two countries, he
said.Iraq is a priority for economic cooperation, he further stated.Aziz also expressed willingness to enhance cooperation in this field,
of the medicine is imported, but the quality and price of the medicine are important factors, he said.Joint cooperation between the two
countries in the production of medicine and medical equipment can meet the needs of the region, he further added.Rise in pharmaceuticals,
pharmaceutical industry, Mohammad Reza Shanehsaz, former head of the Food and Drug Administration, said last October.Today, all medicine
used in the treatment of coronavirus are produced by domestic manufacturers, and if we wanted to import all the items, there would be a high
67 percent of the active pharmaceutical ingredients (APIs) used to produce drugs in Iran were made locally.A total of 227 knowledge-based
firms are supplying medical equipment for health centers across the country, according to the Vice Presidency for Science and
Technology.Knowledge-based companies can produce any medicine effective in countering coronavirus or approved by the scientific committee
within a week to 10 days, Sourena Sattari, vice president for science and technology, said.In January 2021, the Headquarters for Executing
the Order of the Imam unveiled three raw pharmaceuticals and a new anti-coronavirus drug called Ivermectin, which had been previously
imported.Also, Iran is capable of production of biopharmaceuticals, which has so far reached 28 items, making Iran the third leading country
